XML 19 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2019   55,368      
Beginning balance at Dec. 31, 2019 $ 1,284,993 $ 554 $ 3,568,184 $ (1,893) $ (2,281,852)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   204      
Vesting of restricted stock units 0 $ 2 (2)    
Exercise of stock options, shares (in shares)   20      
Exercise of stock options 750   750    
Purchase of common stock under ESPP (in shares)   28      
Purchase of common stock under ESPP 1,872   1,872    
Stock-based compensation 36,335   36,335    
Other comprehensive income (loss) (906)     (906)  
Net loss (202,611)       (202,611)
Ending balance, shares (in shares) at Mar. 31, 2020   55,620      
Ending balance at Mar. 31, 2020 1,120,433 $ 556 3,607,139 (2,799) (2,484,463)
Beginning balance (in shares) at Dec. 31, 2019   55,368      
Beginning balance at Dec. 31, 2019 1,284,993 $ 554 3,568,184 (1,893) (2,281,852)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income (loss) (507)        
Net loss (224,076)        
Ending balance, shares (in shares) at Jun. 30, 2020   66,196      
Ending balance at Jun. 30, 2020 1,682,031 $ 662 4,189,697 (2,400) (2,505,928)
Beginning balance (in shares) at Mar. 31, 2020   55,620      
Beginning balance at Mar. 31, 2020 1,120,433 $ 556 3,607,139 (2,799) (2,484,463)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon public offering, net of issuance costs (in shares)   10,455      
Issuance of common stock upon public offering, net of issuance costs of $33,465 541,536 $ 105 541,431 0 0
Vesting of restricted stock units (in shares)   114      
Vesting of restricted stock units 0 $ 1 (1)    
Exercise of stock options, shares (in shares)   7      
Exercise of stock options 347   347    
Stock-based compensation 40,781   40,781    
Other comprehensive income (loss) 399     399  
Net loss (21,465)       (21,465)
Ending balance, shares (in shares) at Jun. 30, 2020   66,196      
Ending balance at Jun. 30, 2020 $ 1,682,031 $ 662 4,189,697 (2,400) (2,505,928)
Beginning balance (in shares) at Dec. 31, 2020 66,432 66,432      
Beginning balance at Dec. 31, 2020 $ 1,355,056 $ 665 4,260,443 (5,505) (2,900,547)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   294      
Vesting of restricted stock units 0 $ 3 (3)    
Exercise of stock options, shares (in shares)   207      
Exercise of stock options 1,219 $ 2 1,217    
Purchase of common stock under ESPP (in shares)   67      
Purchase of common stock under ESPP 1,707 $ 1 1,706    
Stock-based compensation 36,090   36,090    
Issuance of stock to settle liability-classified restricted stock units (in shares)   422      
Issuance of unrestricted stock awards to settle accrued employee compensation 12,013 $ 4 12,009    
Other comprehensive income (loss) 56     56  
Net loss (205,808)       (205,808)
Ending balance, shares (in shares) at Mar. 31, 2021   67,422      
Ending balance at Mar. 31, 2021 $ 1,200,333 $ 675 4,311,462 (5,449) (3,106,355)
Beginning balance (in shares) at Dec. 31, 2020 66,432 66,432      
Beginning balance at Dec. 31, 2020 $ 1,355,056 $ 665 4,260,443 (5,505) (2,900,547)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options, shares (in shares) 209        
Other comprehensive income (loss) $ (272)        
Net loss $ (447,510)        
Ending balance, shares (in shares) at Jun. 30, 2021 67,551 67,551      
Ending balance at Jun. 30, 2021 $ 984,561 $ 676 4,337,719 (5,777) (3,348,057)
Beginning balance (in shares) at Mar. 31, 2021   67,422      
Beginning balance at Mar. 31, 2021 1,200,333 $ 675 4,311,462 (5,449) (3,106,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   127      
Vesting of restricted stock units 0 $ 1 (1)    
Exercise of stock options, shares (in shares)   2      
Exercise of stock options 36   36    
Stock-based compensation 26,222   26,222    
Other comprehensive income (loss) (328)     (328)  
Net loss $ (241,702)       (241,702)
Ending balance, shares (in shares) at Jun. 30, 2021 67,551 67,551      
Ending balance at Jun. 30, 2021 $ 984,561 $ 676 $ 4,337,719 $ (5,777) $ (3,348,057)